|
Age Related Macular Degeneration
|
1
|
|
AMD
|
1
|
|
ATP
|
1
|
|
biopharmaceutical
|
2
|
|
Biopharmaceutical Manufacturing
|
11
|
|
Biopharmaceuticals
|
2
|
|
Cancer
|
66
|
|
Chemoattractant
|
1
|
|
Combination Therapy
|
2
|
|
Drug Delivery
|
37
|
|
Drug Formulation
|
3
|
|
Drug Manufacturing
|
14
|
|
Griseofulvin
|
1
|
|
Immune Checkpoint Blockage
|
1
|
|
Immunofuctional
|
1
|
|
Immunogenic Cell Death
|
1
|
|
immunotherapy
|
10
|
|
Intraocular Injection
|
2
|
|
Oncology
|
14
|
|
paclitaxel
|
1
|
|
Pharmaceuticals
|
191
|
|
PLGA
|
1
|
|
PLGA microparticles
|
1
|
|
PLGA Nanoparticles
|
1
|
|
Polymeric Nanoparticles
|
1
|
|
Sustained Release
|
3
|
|
Wet macular degeneration
|
1
|
